Jena, February 8, 2012 – Hereby Analytik Jena AG (Prime Standard: AJA, ISIN: DE0005213508) announced that the cash capital increase resolved on January 26, 2012 was entered in the commercial register today.

As part of the capital increase, 470,000 new no-par value bearer shares were placed at a subscription price of EUR 10.48 per share. The Company’s share capital was thus increased from EUR 5,235,465.00 to EUR 5,705,465.00. The shares were fully subscribed by Beteiligungsfonds Thüringer Industriebeteiligungs-GmbH & Co. KG (TIB) managed by bm-t beteilungsmanagement thüringen gmbh (bm-t), Erfurt. As a result its stake in Analytik Jena moved up to 17.79 %.

With the entry of the capital increase into the commercial register at the Registry Court of Jena the new shares are issued and are entitled to profits as of October 1, 2011.

Contact:
Dana Schmidt
Analytik Jena AG
Konrad-Zuse-Strasse 1
07745 Jena | Germany
Phone +49 (0) 36 41 77 92 81
E-mail: ir@analytik-jena.de

Jena (Germany), January 26, 2012 - On January 25, 2012, the Executive Board of Analytik Jena AG (Prime Standard: AJA, ISIN: DE0005213508) utilized the authorization granted by the Annual General Meeting on March 19, 2009 and resolved a cash capital increase from authorized capital. The Super-visory Board of Analytik Jena today approved the capital increase.

The share capital of the Company from the current figure of EUR 5,235,465.00 will be increased by partially utilizing the Authorized Capital by issuing 470,000 new no-par value bearer shares at a sub-scription price of EUR 10.480 per share with shareholders' subscription rights disapplied. The sub-scription price corresponds to the volume-weighted average price on the last five trading days (Xetra) less a discount of 3 %. The new shares will be fully subscribed by the Thüringer Industriebeteiligungs-GmbH & Co. KG (TIB), an investment fund managed by the bm-t beteilungsmanagement thüringen gmbh (bm-t), Erfurt. bm-t already holds an interest in Analytik Jena AG of 10.41 % and thus increases its stake to 17.79 %.

Analytik Jena AG intends to use the proceeds from the capital increase to finance the strategic devel-opment of the Company.

Analytik Jena has commissioned IKB Deutsche Industriebank AG to manage the transaction.

"Following a successful 2010/2011 financial year, we are looking to continue Analytik Jena's growth path. The proceeds from the capital increase will be used for the further expansion of our business, particularly through additions to our portfolio that offer significant synergy effects. However, we cannot make any concrete statements at present," commented Klaus Berka, CEO of Analytik Jena AG. "We are pleased that, with its investment, bm-t is backing Analytik Jena's growth policy and strongly positioning itself as a long-term strategic investor."

Contact:
Dana Schmidt
Analytik Jena AG
Konrad-Zuse-Strasse 1
07745 Jena | Germany
Phone: +49 (0) 36 41 77 92 81
E-mail: ir@analytik-jena.com

• Sales record based on sound business development
• Operating result considerably higher than previous year
• Result influenced by extraordinary tax expenses relating to other periods
• Growth expected for financial year 2011/2012 with a quieter first quarter

Jena, December 15, 2011 — In the past financial year 2010/2011, the Analytik Jena AG (Frankfurt DE0005213508, Prime Standard: AJA) was again able to increase its revenue significantly. Overall, the Group generated sales of EUR 86.3 m (previous year: EUR 80.2 m), a 7.6 % increase on the previous year. In the process, Analytik Jena again surpassed the record achieved in the previous year. Operating profit (EBIT) amounted to EUR 5.0 m (previous year: EUR 3.1 m), up 59.3 % year-on-year.

"After the previous financial year was basically characterized by one-time effects, we succeeded in growing our operating result again.“ commented Klaus Berka, CEO of Analytik Jena AG. “We could again increase in sales and exceed the record level of sales we set last year. We achieved this due to the outstanding development in our largest business area, Analytical Instrumentation that managed to grow its revenue by 11.3 % last year based on its traditionally strong export operations."

Revenue Development and Segments

From a strong competitive position in the optical spectroscopy sector, the Analytical Instrumentation business unit was again able to win market share in the reporting period and increase its revenue. Analytik Jena closed the financial year in this segment with revenue of EUR 53.2 m (previous year: EUR 47.8 m), representing a gain of 11.3 %. Life Science business unit recorded sales of EUR 28.3 m (previous year: EUR 27.5 m), 2.7 % higher than in the previous year. The Optics segment was able to halt a three-year downward slide caused by economic conditions, nearly matching the previous year’s level. Revenue in financial year 2010/2011 totaled EUR 4.8 m (previous year: EUR 4.9 m). That equates to a slight decrease of 1.1 %.

Financial Position and Results of Operations

The Group ended the full financial year of 2010/2011 with earnings before interest, taxes, depreciation, and amortization (EBITDA) of EUR 8.8 m (previous year: EUR 6.7 m) and operating profit of EUR 5.0 m (previous year: EUR 3.1 m). In the process, Analytik Jena recorded increases in EBITDA of 31.0 % and EBIT of 59.3 %. Once again, the Company achieved a double-digit EBITDA margin of 10.2 % (previous year: 8.4 %). The EBIT margin was 5.8 % compared with 3.9 % in the previous year. Therefore, Analytik Jena performed much better on an operating basis than in the previous year.

The Group’s tax expense totaled EUR 2.6 m (previous year: EUR 1.1 m). Of this amount, EUR 0.8 m accrues to current actual tax expense and deferred tax income. This corresponds to a tax rate of 27.6 %. In addition, tax expense of EUR 1.8 m includes non-period tax expense resulting from the agreement with the Gera tax office in financial year 2010/2011. The consolidated net profit for the year fell compared with the amount for the previous year by 90.7 % and totaled EUR 0.2 m (previous year: EUR 2.1 m). For the shareholders of Analytik Jena AG both basic and diluted earnings per share amounted to EUR -0.03 (previous year: EUR 0.34).

The Group’s total assets as of the balance sheet date on September 30, 2011 remained similar to the previous year’s level and amounted to EUR 83.6 m.

Human Resources

As of September 30, 2011, the Group had a total of 802 employees, including 38 interns (previous year: 796 employees, including 49 interns), or 0.8 % more than as of the previous balance sheet date.

Outlook

With respect to the financial year 2011/2012, Analytik Jena expects that it will be able to achieve further increases in revenue and earnings in all three business units. The Company expects that revenue will be distributed relatively evenly over the quarters and that no major disruptions will be caused by large projects.

"The Company plans further investments in the expansion of the Thuringian manufacturing site in Langewiesen amounting to about EUR 0.7 and remains clearly committed to the manufacturing site Germany. Further important milestones are the market launch of some product innovations that are meant to contribute to the stable growth of the segments. We especially expect good impetus for the expansion of our business from the prestigious international trade fairs IWA in Nuremberg at the beginning of March concerning Optics and the 'analytica' in April in Munich concerning both segments Analytical Instrumentation and Life Science." Berka added.

The full financial report can be accessed at http://berichte.analytik-jena.de/AnnualReport1011.pdf .

Jena/Yokohama, December 13, 2011 — Analytik Jena AG is expanding its product range in Japan, the world’s third-largest market for analytical measurement technology. As part of a sales partnership with Japanese company Techno-X, the Japanese subsidiary of the Jena-based Group will in future offer instruments for X-ray fluorescence spectroscopy, a method of determining the concentrations of elements in liquid and solid samples in cases where, unlike with other processes, the sample must not be destroyed for or during the analysis.

"With the products of our new partner, Techno-X, we are expanding our product portfolio with the addition of X-ray fluorescence equipment, which addresses what is a global growth market. The initial plan is to operate only on the Japanese market, where these products are already familiar," comments Klaus Berka, CEO of Analytik Jena AG. "Our goal is to achieve sales of EUR 1.5 to 2.0 million in the current financial year alone."

The Japanese company Techno-X was established in 2009 and employs 25 people. As part of the sales cooperation, Analytik Jena is fully incorporating the sales team of its new partner into the sales structures of its Japanese subsidiary.

"We hope to strengthen our market position in Japan by combining our partner’s technological expertise in the field of X-ray fluorescence spectroscopy with the sales skills of Analytik Jena. In the future, Techno-X will be able to dedicate greater focus to research and development," continues Berka.

X-ray fluorescence spectrometers are used by Techno-X for such applications as on-site analysis — for example, in the field of petrochemistry to analyze sulfur and chlorine — or in food inspection laboratories for analyzing the cadmium content of rice, for instance. In X-ray fluorescence spectroscopy, the samples are exposed to practically non-destructive X-rays, which means that the sample can be analyzed both qualitatively and quantitatively in terms of its chemical composition.

• Sales Increase of 7.6 % to 86.3 m EUR achieved
  
• With 5.0 m EUR operative result increased of 59.3 %
  
• Investigation of AJZ Engineering closed
  
• Non-recurrent provision for tax arrears payment negatively impact EPS

Jena (Germany), November 21, 2011 — Analytik Jena AG (Frankfurt DE0005213508, Prime Standard: AJA) achieved a sales growth of 7.6 % and an increase in the operating earnings of 59.3 % in the past financial year 2010/2011. The Company generated total sales for the Group of EUR 86.3 m (previous year: EUR 80.2 m) and an operating result (EBIT) of EUR 5.0 m (previous year: EUR 3.1 m).

The growth rates in sales and earnings were generated in both core business units Analytical Instrumentation and Life Science. The pure organic growth especially resulted from increasing foreign sales. The Company particularly participated from a disproportional growth in the Asian countries, where business increased by 20.4 %. "We have achieved our revenue and earnings targets and have returned to a profitable operating earnings growth", said Klaus Berka, CEO of Analytik Jena AG. "Supported by an excellent start into the past financial year as well as a strong year-end business our two core business units Analytical Instrumentation and Life Science showed a stable revenue growth. In our smallest business unit Optics we have been able to stop the dramatic collapse in the past years."

In the operating business Analytik Jena AG showed again a considerable increase compared to the previous year. The Group closed the last full financial year 2010/11 with earnings before interest, taxes, depreciation, and amortization (EBITDA) amounting to EUR 8.8 m (previous year: EUR 6.7 m) which corresponds to an increase by 31.0 %. The EBITDA margin amounts to 10.2 % (previous year: 8.4 %). The operating profit (EBIT) amounts to EUR 5.0 m (previous year: EUR 3.1 m) and therewith increased by 59.3 % compared to the previous year. The EBIT margin improved to 5.8 % in comparison to 3.9 % in the previous year.

On November 16, 2011, the tax audit of AJZ Engineering GmbH conducted by Gera Tax Office was consensually closed with an agreement. Due to the profit and loss transfer agreement that existed between AJZ Engineering and the parent company, Analytik Jena is faced with tax expenses. Extraordinary expenses totaling EUR 1.2 m arise for the 2003 to 2007 financial years. Tax arrears payment, that also includes effects of EUR 1.0 m for subsequent years, was completely booked in the past financial year and has a negatively impact on the EBT (interest expense) and the Earnings per Share (EPS). The investigations into AJZ Engineering have already been closed at the end of September against payment of an amount of EUR 300 thousand.

"For Analytik Jena as well as for AJZ Engineering we have now again planning reliability for the further business development. The substantial additional expenses due to the incidents effecting our subsidiary will no longer have an impact on us. Stand alone, Analytik Jena together with majority shareholder LBPS Management Holding GmbH is looking for strategic investors for an equity holding in AJZ Engineering. Our goal is to further reduce the risks for Analytik Jena AG, which are inherent to the volatile and capital committing project business. There is no concrete timetable for this yet", continues Berka.

The figures given in the announcement are preliminary figures. The final results for the 2010/2009 financial year (as at September 30) will be announced by the Group on December 15, 2011.